Clinical evaluation of immunoinhibition determination of creatine kinase B subunits in coronary care.
One hundred patients with chest pain of cardiac origin were evaluated on the basis of clinical findings, electrocardiograph results, and total creatine kinase (CK) and creatine kinase B-subunit (CK-B) activity (as determined by immunoinhibition with the Boehringer CK-MB kit) in serum. All patients diagnosed as having had an acute myocardial infarction had increased values for both CK-B and total CK. In no case was normal total CK activity associated with an increased CK-B, nor was normal CK-B associated with an increased total CK. During collection of data for reference ranges, we found 10 patients who had no evidence of cardiac disease but had various other diseases, who exhibited high values for CK-B in serum; four of these had normal values for total CK. We conclude that estimations of CK-B in serum by this method added no more diagnostic information than did data on total CK in the evaluation of chest pain.
D000368:Aged; D003402:Creatine Kinase / Q000097:blood*; D004562:Electrocardiography; D005189:False Positive Reactions; D006801:Humans; D007527:Isoenzymes; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis*; D010146:Pain / Q000209:etiology; D011933:Reagent Kits, Diagnostic
D007527:Isoenzymes; D011933:Reagent Kits, Diagnostic; D003402:Creatine Kinase